These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16864105)

  • 1. [Bevacizumab (Avastin) inhibits lung cancer-induced pulmonary microvascular angiogenesis].
    Liu JX; Wang XG; Fu J; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1027-9, 1043. PubMed ID: 16864105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of vascular endothelial growth factor antibody Avastin on angiogenesis of human gastric cancer growing orthotopically in nude mice].
    Wang N; Wang B; Wang YJ
    Ai Zheng; 2006 Sep; 25(9):1076-81. PubMed ID: 16965645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of YangZheng XiaoJi Extract, DME-25, on Endothelial Cells and their Response to Avastin.
    Owen S; Gao Y; Zhi X; Wei C; Wu Y; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1181-92. PubMed ID: 26977014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-angiogenic effect of vinorelbine in combination with cetuximab in vitro and in vivo].
    Qian XP; Liu BR; Wan L; Hu J; Zhu LJ; Yu LX
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):253-7. PubMed ID: 20510073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice.
    Ninomiya S; Inomata M; Tajima M; Ali AT; Ueda Y; Shiraishi N; Kitano S
    J Surg Res; 2009 Jun; 154(2):196-202. PubMed ID: 19329124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.
    Goto H; Yano S; Zhang H; Matsumori Y; Ogawa H; Blakey DC; Sone S
    Cancer Res; 2002 Jul; 62(13):3711-5. PubMed ID: 12097279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis.
    Ricci AG; Olivares CN; Bilotas MA; Meresman GF; Barañao RI
    Reprod Sci; 2011 Jul; 18(7):614-22. PubMed ID: 21266664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study.
    Costa R; Carneiro A; Rocha A; Pirraco A; Falcão M; Vasques L; Soares R
    J Cell Biochem; 2009 Dec; 108(6):1410-7. PubMed ID: 19859900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of suramin in combination with cisplatin on growth and metastasis of lung adenocarcinoma xenografts in mice].
    Zhang P; He JB; Ou LW; Wang XH
    Ai Zheng; 2006 Apr; 25(4):409-13. PubMed ID: 16613671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer.
    Liu LZ; Fang J; Zhou Q; Hu X; Shi X; Jiang BH
    Mol Pharmacol; 2005 Sep; 68(3):635-43. PubMed ID: 15947208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
    de Gramont A; Van Cutsem E
    Oncology; 2005; 69 Suppl 3():46-56. PubMed ID: 16301835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium caffeate induces endothelial cell apoptosis and inhibits VEGF expression in cancer cells.
    Xu F; Ou-Yang ZG; Zhang SH; Song DQ; Shao RG; Zhen YS
    Yao Xue Xue Bao; 2006 Jun; 41(6):572-6. PubMed ID: 16927835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
    Singh RP; Dhanalakshmi S; Agarwal C; Agarwal R
    Oncogene; 2005 Feb; 24(7):1188-202. PubMed ID: 15558015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
    Ferrara N; Hillan KJ; Novotny W
    Biochem Biophys Res Commun; 2005 Jul; 333(2):328-35. PubMed ID: 15961063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.